Carisma Therapeutics Statistics
Total Valuation
CARM has a market cap or net worth of $71.04 million. The enterprise value is -$3.44 million.
Market Cap | 71.04M |
Enterprise Value | -3.44M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CARM has 41.54 million shares outstanding. The number of shares has increased by 1,475.33% in one year.
Shares Outstanding | 41.54M |
Shares Change (YoY) | +1,475.33% |
Shares Change (QoQ) | -16.78% |
Owned by Insiders (%) | 28.68% |
Owned by Institutions (%) | 40.82% |
Float | 22.51M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.76 |
Forward PS | 4.20 |
PB Ratio | 2.68 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.12.
Current Ratio | 5.06 |
Quick Ratio | n/a |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 45.88 |
Financial Efficiency
Return on equity (ROE) is -154.00% and return on invested capital (ROIC) is -299.21%.
Return on Equity (ROE) | -154.00% |
Return on Assets (ROA) | -71.60% |
Return on Capital (ROIC) | -299.21% |
Revenue Per Employee | $139,430 |
Profits Per Employee | -$811,953 |
Employee Count | 107 |
Asset Turnover | 0.12 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.99% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -57.99% |
50-Day Moving Average | 2.25 |
200-Day Moving Average | 3.75 |
Relative Strength Index (RSI) | 33.27 |
Average Volume (30 Days) | 163,830 |
Short Selling Information
The latest short interest is 1.58 million, so 3.81% of the outstanding shares have been sold short.
Short Interest | 1.58M |
Short Previous Month | 1.55M |
Short % of Shares Out | 3.81% |
Short % of Float | 7.03% |
Short Ratio (days to cover) | 9.65 |
Income Statement
In the last 12 months, CARM had revenue of $14.92 million and -$86.88 million in losses. Loss per share was -$2.59.
Revenue | 14.92M |
Gross Profit | 14.92M |
Operating Income | -88.73M |
Pretax Income | -86.88M |
Net Income | -86.88M |
EBITDA | -80.55M |
EBIT | -88.82M |
Loss Per Share | -$2.59 |
Balance Sheet
The company has $77.61 million in cash and $3.12 million in debt, giving a net cash position of $74.48 million or $1.79 per share.
Cash & Cash Equivalents | 77.61M |
Total Debt | 3.12M |
Net Cash | 74.48M |
Net Cash Per Share | $1.79 |
Equity / Book Value | 26.53M |
Book Value Per Share | 0.64 |
Working Capital | 64.56M |
Cash Flow
In the last 12 months, operating cash flow was -$81.18 million and capital expenditures -$1.13 million, giving a free cash flow of -$82.31 million.
Operating Cash Flow | -81.18M |
Capital Expenditures | -1.13M |
Free Cash Flow | -82.31M |
FCF Per Share | -$2.46 |
Margins
Gross margin is 100.00%, with operating and profit margins of -594.75% and -582.34%.
Gross Margin | 100.00% |
Operating Margin | -594.75% |
Pretax Margin | -582.34% |
Profit Margin | -582.34% |
EBITDA Margin | -539.92% |
EBIT Margin | -595.31% |
FCF Margin | -551.71% |
Dividends & Yields
CARM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1,475.33% |
Shareholder Yield | -1,475.33% |
Earnings Yield | -122.30% |
FCF Yield | -115.87% |
Analyst Forecast
The average price target for CARM is $9.40, which is 449.71% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $9.40 |
Price Target Difference | 449.71% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 42.77% |
EPS Growth Forecast (5Y) | -28.79% |
Stock Splits
The last stock split was on March 8, 2023. It was a reverse split with a ratio of 1:20.
Last Split Date | Mar 8, 2023 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
CARM has an Altman Z-Score of -5.4 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.4 |
Piotroski F-Score | 4 |